Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Supply Chain

Jeil Pharmaceutical Co

+ Add to Watchlist

002620:KS

33,200 KRW 250 0.75%

As of 02:18:34 ET on 05/22/2015.

Snapshot for Jeil Pharmaceutical Co (002620)

Open: 33,950 Day's Range: 32,800 - 34,700 Volume: 53,925
Previous Close: 33,450 52wk Range: 17,000 - 34,850 1-Yr Rtn: +52.71%

Stock Chart for 002620

No chart data available.
  • 002620:KS 33,200
  • 1D
  • 1M
  • 1Y
33,450
Interactive 002620 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002620

Current P/E Ratio (ttm) 190.8046
Estimated P/E(-) -
Relative P/E vs. KOSPI -
Earnings Per Share (ttm) 174.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 493,020.00
Shares Outstanding (M) 14.85
30 Day Average Volume 46,179
Price/Book (mrq) 1.8071
Price/Sale (ttm) 0.8012
Dividend Indicated Gross Yield 0.18%
Cash Dividend (KRW) 60.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -9.71%
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002620

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 002620

Jeil Pharmaceutical Company manufactures a variety of prescription drugs for hospital use. The Company specializes in producing antiphlogistic painkiller and arthritic medications.

Han Seung-SooChairmanSung Suk-JePresident/Rep Director
Han Sang-ChulVice PresidentRyu Seung-ChulSenior Managing Director
More Company Profile & Key Executives for 002620

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil